Takeda 12-Month Price Target Raised to $21.12
The headline reports a raised 12-month price target of $21.12 for Takeda Pharmaceutical Company Limited.
The headline reports a raised 12-month price target of $21.12 for Takeda Pharmaceutical Company Limited.